Cargando…

The impact of antihypertensives on kidney disease

Arterial hypertension and chronic kidney disease (CKD) are intimately related. The control of blood pressure (BP) levels is strongly recommended in patients with CKD in order to protect the kidney against the accompanying elevation in global cardiovascular (CV) risk. Actually, the goal BP in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marquez, Diego F, Ruiz-Hurtado, Gema, Ruilope, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414822/ https://www.ncbi.nlm.nih.gov/pubmed/28529721 http://dx.doi.org/10.12688/f1000research.9916.1

Ejemplares similares

Microalbuminuria and cardiorenal risk: old and new evidence in different populations
por: Márquez, Diego Francisco, et al.
Publicado: (2019)

Age and blood pressure goal in women with prior coronary events
por: Ruilope, Luis M., et al.
Publicado: (2020)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

Exercise Reduces Ambulatory Blood Pressure in Patients With Hypertension: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Saco‐Ledo, Gonzalo, et al.
Publicado: (2020)

Renal denervation in the antihypertensive arsenal – knowns and known unknowns
por: Messerli, Franz H., et al.
Publicado: (2023)

Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection
por: Haruhara, Kotaro, et al.
Publicado: (2022)

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019)

Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: Navarro-García, José Alberto, et al.
Publicado: (2021)

Antihypertensive Medications and Change in Stages of Chronic Kidney Disease
por: Komaroff, Marina, et al.
Publicado: (2018)

Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease
por: Manzano-Lista, Francisco Javier, et al.
Publicado: (2022)

Genetic Deletion of NOD1 Prevents Cardiac Ca(2+) Mishandling Induced by Experimental Chronic Kidney Disease
por: Gil-Fernández, Marta, et al.
Publicado: (2020)

Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease
por: Alvarez-Llamas, Gloria, et al.
Publicado: (2022)

Plants Used as Antihypertensive
por: Verma, Tarawanti, et al.
Publicado: (2020)

Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury
por: González-Lafuente, Laura, et al.
Publicado: (2023)

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
por: Vázquez-Sánchez, Sara, et al.
Publicado: (2021)

Role of Chrononutrition in the Antihypertensive Effects of Natural Bioactive Compounds
por: Ibarz-Blanch, Néstor, et al.
Publicado: (2022)

Xerostomia and Salivary Flow in Patients Taking Antihypertensive Drugs
por: Ramírez Martínez-Acitores, Lucía, et al.
Publicado: (2020)

Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs
por: Satoh, Michihiro, et al.
Publicado: (2020)

Effect of Chronotherapy of Antihypertensives in Chronic Kidney Disease: A Randomized Control Trial
por: Tiwari, Vaibhav, et al.
Publicado: (2021)

Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT
por: Sarafidis, Pantelis, et al.
Publicado: (2020)

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension
por: Santiago-Hernandez, Aranzazu, et al.
Publicado: (2021)

Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial
por: Zhu, Dingliang, et al.
Publicado: (2013)

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
por: Basile, J N
Publicado: (2009)

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
por: Ito, Sadayoshi, et al.
Publicado: (2020)

Persistence and compliance with newly initiated antihypertensive drug treatment in patients with chronic kidney disease
por: Truong, Viet Thanh, et al.
Publicado: (2016)

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
por: Ruilope, Luis M
Publicado: (2008)

Valorization of Chicken Slaughterhouse Byproducts to Obtain Antihypertensive Peptides
por: Bravo, Francisca Isabel, et al.
Publicado: (2023)

Antihypertensive Properties of Plant-Based Prebiotics
por: Yeo, Siok-Koon, et al.
Publicado: (2009)

Antihypertensive Peptides from Milk Proteins
por: Jäkälä, Pauliina, et al.
Publicado: (2010)

Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
por: Agarwal, Rajiv, et al.
Publicado: (2020)

Evaluation of antihypertensive therapy in diabetic hypertensive patients: impact of ischemic heart disease
por: Sweileh, Waleed M., et al.
Publicado: (2009)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

The Impact of Non-Adherence to Antihypertensive Drug Therapy
por: Gardezi, Syed Karam Mustafa, et al.
Publicado: (2023)

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?
por: Miyazaki, Hiroki, et al.
Publicado: (2015)

The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction
por: Rojas-Franco, Placido, et al.
Publicado: (2022)

Antihypertensive Treatment in Severe Aortic Stenosis
por: Kang, Tae Soo, et al.
Publicado: (2018)

Withdrawal of antihypertensive medication: a systematic review
por: van der Wardt, Veronika, et al.
Publicado: (2017)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_efnd67ee5qoucj9e3cuog7s8t5